Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis

Psychopharmacology (Berl). 2015 Feb;232(3):519-28. doi: 10.1007/s00213-014-3684-1. Epub 2014 Jul 20.

Abstract

Rationale: An acute challenge with delta-9-tetrahydrocannabinol (THC) can induce psychotic symptoms including delusions. High electroencephalography (EEG) frequencies, above 20 Hz, have previously been implicated in psychosis and schizophrenia.

Objectives: The objective of this study is to determine the effect of intravenous THC compared to placebo on high-frequency EEG.

Methods: A double-blind cross-over study design was used. In the resting state, the high-beta to low-gamma magnitude (21-45 Hz) was investigated (n = 13 pairs + 4 THC only). Also, the event-related synchronisation (ERS) of motor-associated high gamma was studied using a self-paced button press task (n = 15).

Results: In the resting state, there was a significant condition × frequency interaction (p = 0.00017), consisting of a shift towards higher frequencies under THC conditions (reduced high beta [21-27 Hz] and increased low gamma [27-45 Hz]). There was also a condition × frequency × location interaction (p = 0.006), such that the reduction in 21-27-Hz magnitude tended to be more prominent in anterior regions, whilst posterior areas tended to show greater 27-45-Hz increases. This effect was correlated with positive symptoms, as assessed on the Positive and Negative Syndrome Scale (PANSS) (r = 0.429, p = 0.042). In the motor task, there was a main effect of THC to increase 65-130-Hz ERS (p = 0.035) over contra-lateral sensorimotor areas, which was driven by increased magnitude in the higher, 85-130-Hz band (p = 0.02) and not the 65-85-Hz band.

Conclusions: The THC-induced shift to faster gamma oscillations may represent an over-activation of the cortex, possibly related to saliency misattribution in the delusional state.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Waves / drug effects*
  • Cannabinoid Receptor Agonists / pharmacology*
  • Cerebral Cortex / drug effects*
  • Cross-Over Studies
  • Double-Blind Method
  • Dronabinol / pharmacology*
  • Female
  • Humans
  • Male
  • Young Adult

Substances

  • Cannabinoid Receptor Agonists
  • Dronabinol